科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/01/06 | 4,235 | 4,255 | 4,090 | 4,105 | +70 | +1.7% | 442,800 |
| 2021/01/05 | 4,045 | 4,060 | 3,985 | 4,035 | +25 | +0.6% | 272,800 |
| 2021/01/04 | 4,000 | 4,015 | 3,985 | 4,010 | +25 | +0.6% | 133,500 |
| 2020/12/30 | 3,995 | 4,005 | 3,945 | 3,985 | -10 | -0.3% | 122,900 |
| 2020/12/29 | 3,950 | 3,995 | 3,935 | 3,995 | +75 | +1.9% | 103,600 |
| 2020/12/28 | 3,950 | 3,970 | 3,900 | 3,920 | -5 | -0.1% | 79,400 |
| 2020/12/25 | 3,960 | 3,965 | 3,915 | 3,925 | -30 | -0.8% | 67,000 |
| 2020/12/24 | 3,945 | 3,965 | 3,930 | 3,955 | +50 | +1.3% | 105,800 |
| 2020/12/23 | 3,925 | 3,940 | 3,905 | 3,905 | +20 | +0.5% | 99,100 |
| 2020/12/22 | 3,880 | 3,910 | 3,845 | 3,885 | -30 | -0.8% | 146,100 |
| 2020/12/21 | 3,945 | 3,955 | 3,850 | 3,915 | +35 | +0.9% | 191,800 |
| 2020/12/18 | 3,855 | 3,905 | 3,810 | 3,880 | +15 | +0.4% | 271,400 |
| 2020/12/17 | 3,875 | 3,875 | 3,830 | 3,865 | -15 | -0.4% | 196,100 |
| 2020/12/16 | 3,895 | 3,940 | 3,860 | 3,880 | -30 | -0.8% | 150,400 |
| 2020/12/15 | 3,895 | 3,945 | 3,860 | 3,910 | -35 | -0.9% | 225,400 |
| 2020/12/14 | 3,940 | 3,980 | 3,910 | 3,945 | +5 | +0.1% | 124,800 |
| 2020/12/11 | 3,945 | 3,960 | 3,900 | 3,940 | -25 | -0.6% | 149,100 |
| 2020/12/10 | 3,890 | 3,975 | 3,890 | 3,965 | +60 | +1.5% | 153,100 |
| 2020/12/09 | 3,900 | 3,920 | 3,885 | 3,905 | +45 | +1.2% | 124,100 |
| 2020/12/08 | 3,850 | 3,870 | 3,825 | 3,860 | -5 | -0.1% | 117,700 |
| 2020/12/07 | 3,900 | 3,920 | 3,865 | 3,865 | ±0 | ±0% | 97,800 |
| 2020/12/04 | 3,895 | 3,910 | 3,855 | 3,865 | +10 | +0.3% | 147,400 |
| 2020/12/03 | 3,850 | 3,875 | 3,810 | 3,855 | +50 | +1.3% | 148,800 |
| 2020/12/02 | 3,875 | 3,875 | 3,805 | 3,805 | -50 | -1.3% | 211,100 |
| 2020/12/01 | 3,840 | 3,885 | 3,825 | 3,855 | +45 | +1.2% | 177,500 |
| 2020/11/30 | 3,935 | 3,945 | 3,805 | 3,810 | -145 | -3.7% | 323,200 |
| 2020/11/27 | 3,910 | 3,960 | 3,885 | 3,955 | +65 | +1.7% | 217,500 |
| 2020/11/26 | 3,860 | 3,890 | 3,815 | 3,890 | +40 | +1% | 275,500 |
| 2020/11/25 | 3,860 | 3,885 | 3,850 | 3,850 | -5 | -0.1% | 261,900 |
| 2020/11/24 | 3,915 | 3,935 | 3,855 | 3,855 | -20 | -0.5% | 156,500 |
| 2020/11/20 | 3,910 | 3,915 | 3,855 | 3,875 | -75 | -1.9% | 192,200 |
| 2020/11/19 | 3,960 | 3,960 | 3,920 | 3,950 | -5 | -0.1% | 148,600 |
| 2020/11/18 | 4,000 | 4,005 | 3,955 | 3,955 | -55 | -1.4% | 137,500 |
| 2020/11/17 | 4,020 | 4,035 | 3,980 | 4,010 | -15 | -0.4% | 180,900 |
| 2020/11/16 | 4,065 | 4,065 | 3,975 | 4,025 | -35 | -0.9% | 447,700 |
| 2020/11/13 | 4,120 | 4,120 | 4,010 | 4,060 | -80 | -1.9% | 190,100 |
| 2020/11/12 | 4,130 | 4,160 | 4,105 | 4,140 | +35 | +0.9% | 176,000 |
| 2020/11/11 | 4,275 | 4,275 | 4,090 | 4,105 | -100 | -2.4% | 231,000 |
| 2020/11/10 | 4,295 | 4,295 | 4,175 | 4,205 | +5 | +0.1% | 160,900 |
| 2020/11/09 | 4,150 | 4,210 | 4,080 | 4,200 | +5 | +0.1% | 248,900 |
| 2020/11/06 | 4,225 | 4,225 | 4,040 | 4,195 | -110 | -2.6% | 253,600 |
| 2020/11/05 | 4,305 | 4,355 | 4,250 | 4,305 | +5 | +0.1% | 185,400 |
| 2020/11/04 | 4,275 | 4,315 | 4,255 | 4,300 | +95 | +2.3% | 194,600 |
| 2020/11/02 | 4,140 | 4,260 | 4,140 | 4,205 | +100 | +2.4% | 135,600 |
| 2020/10/30 | 4,195 | 4,195 | 4,090 | 4,105 | -110 | -2.6% | 112,900 |
| 2020/10/29 | 4,190 | 4,230 | 4,170 | 4,215 | +30 | +0.7% | 173,900 |
| 2020/10/28 | 4,280 | 4,285 | 4,140 | 4,185 | -135 | -3.1% | 149,300 |
| 2020/10/27 | 4,350 | 4,350 | 4,290 | 4,320 | -35 | -0.8% | 162,600 |
| 2020/10/26 | 4,360 | 4,445 | 4,340 | 4,355 | -20 | -0.5% | 75,900 |
| 2020/10/23 | 4,375 | 4,395 | 4,365 | 4,375 | -20 | -0.5% | 80,500 |
1051～
1100
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 61,900円 | +21.1% | - | 0.00% | 15.37倍 | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,700円 | +5.0% | +1.5% | 0.00% | 16.11倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
